Bio-Techne
TECH
#1410
Rank
HK$99.37 B
Marketcap
HK$626.41
Share price
5.03%
Change (1 day)
12.55%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of June 2024 : HK$3.27 B

According to Bio-Techne's latest financial reports the company's total debt is HK$3.27 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30HK$3.56 B39.37%
2022-06-30HK$2.55 B-21.68%
2021-06-30HK$3.26 B-2.79%
2020-06-30HK$3.35 B-14.87%
2019-06-30HK$3.94 B48.35%
2018-06-30HK$2.66 B-0.86%
2017-06-30HK$2.68 B263.11%
2016-06-30HK$0.73 B23.77%
2015-06-30HK$0.59 B495.08%
2014-06-30HK$0.10 B
2006-06-30HK$0.10 B-8.19%
2005-06-30HK$0.11 B-8.15%
2004-06-30HK$0.12 B-7.18%
2003-06-30HK$0.13 B-5.22%
2002-06-30HK$0.14 B-4.83%
2001-06-30HK$0.14 B-4.1%
2000-06-30HK$0.15 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
HK$275.98 B 8,339.04%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.85 B 231.95%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$150.62 B 4,505.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$132.59 B 3,954.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.92 B 234.09%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$153.35 B 4,589.21%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$56.57 M-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA